Jean Marc Extra
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Emergency Medical Services top 1%
- Central Venous Catheters and Hemodialysis
Papers in
-
- Chemotherapy-related skin toxicity 3
- Co-authors
- M. MartyPaul CottuGuy MeyerB. LorcerieDominique FargeZora MarjanovicChristine Le MaignanPhilippe Solal‐Céligny
- Journals
- European Journal of Cancer (2 papers)PharmacoEconomics (1 paper)Pathobiology (1 paper)Leukemia Research (1 paper)Journal of Neuro-Oncology (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Jean Marc Extra
21 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Internal Medicine 589
- Emergency Medical Services 256
- Oncology 857
- Cardiology and Cardiovascular Medicine 438
- Hematology 173
Countries citing papers authored by Jean Marc Extra
This map shows the geographic impact of Jean Marc Extra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Marc Extra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Marc Extra more than expected).
Fields of papers citing papers by Jean Marc Extra
This network shows the impact of papers produced by Jean Marc Extra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Marc Extra. The network helps show where Jean Marc Extra may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean Marc Extra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2013 | 10 | |
| 3 | 2009 | 69 | |
| 4 | Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer Hit paper breakdown → | 2002 | 620 |
| 5 | 1999 | 15 | |
| 6 | 1998 | 34 | |
| 7 | 1997 | 48 | |
| 8 | 1995 | 8 | |
| 9 | 1995 | 149 | |
| 10 | 1994 | 22 | |
| 11 | 1994 | 8 | |
| 12 | Taxoids: a new class of cytotoxic agents. | 1994 | 3 |
| 13 | Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients. | 1994 | 134 |
| 14 | Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion. | 1993 | 227 |
| 15 | New cytotoxic drugs in clinical development. | 1991 | 1 |
| 16 | 1990 | 295 | |
| 17 | 5HT3-antagonist receptors: their role in drug-induced emesis. | 1990 | 1 |
| 18 | 1987 | 5 | |
| 19 | Treatment of 218 adult acute lymphoblastic leukemias. | 1987 | 16 |
| 20 | 1986 | 8 |
About Jean Marc Extra
Jean Marc Extra is a scholar working on Hematology, Dermatology, Cancer Research, Oncology and Genetics, having authored 21 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers), Chemotherapy-related skin toxicity (3 papers), Lung Cancer Research Studies (3 papers), Cancer Genomics and Diagnostics (3 papers), Breast Cancer Treatment Studies (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Internal Medicine (589 citations), Emergency Medical Services (256 citations), Oncology (857 citations), Cardiology and Cardiovascular Medicine (438 citations) and Hematology (173 citations). Jean Marc Extra has collaborated with scholars based in France and United States. Frequent co-authors include M. Marty, Paul Cottu, Guy Meyer, B. Lorcerie, Dominique Farge, Zora Marjanovic, Christine Le Maignan, Philippe Solal‐Céligny, Y Gruel and Marc Espié. Their work appears in journals such as European Journal of Cancer, PharmacoEconomics, Pathobiology, Leukemia Research and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.